Game Over, Cancer: How AI Is Building the Perfect Drug Combo to Defeat Stubborn Leukemia 

In the battle against cancer, a significant hurdle is the inevitable return of the disease, known as relapsed/refractory (R/R) disease. This is particularly true for Acute Myeloid Leukemia (AML), a highly aggressive blood cancer where patients